We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+12.2%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$483M
AUM Growth
+$37.3M
Cap. Flow
-$6.9M
Cap. Flow %
-1.43%
Top 10 Hldgs %
44.28%
Holding
54
New
2
Increased
–
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$2.36M
2
PACB icon
Pacific Biosciences
PACB
+$2M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$3.23M
2
FISV
Fiserv Inc
FISV
+$2.6M
3
BDX icon
Becton Dickinson
BDX
+$2.46M
4
AAPL icon
Apple
AAPL
+$1.36M
5
RTX icon
RTX Corp
RTX
+$727K

Sector Composition

Rank Sector Weight
1 Technology 26.02%
2 Healthcare 20.2%
3 Industrials 16.73%
4 Consumer Discretionary 13.43%
5 Communication Services 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
51
Becton Dickinson
BDX
$51.6B
– –
-10,250
Closed -$2.46M
FISV
52
Fiserv Inc
FISV
$28.3B
– –
-24,000
Closed -$2.6M
TDOC icon
53
Teladoc Health
TDOC
$1.18B
– –
-25,470
Closed -$3.23M
VNT icon
54
Vontier
VNT
$4.43B
– –
-6,000
Closed -$202K
1 2
3

Similar funds

PLU
Performa Ltd (US) Charleston, South Carolina $620M AUM 19.43% 1-Year Est. Return
RR
Robotti Robert $620M AUM 55.18% 1-Year Est. Return
TAIM
Te Ahumairangi Investment Management Wellington, New Zealand $620M AUM 14.43% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $619M AUM 14.72% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $621M AUM 15.59% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return

Chad R. Baker's Q4 2021 Portfolio in Review

As of Q4 2021, Chad R. Baker held 54 positions worth $483M, up 8.4% from $446M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Chad R. Baker's Q4 2021 filing shows 2 new, 4 reduced and 4 closed positions. Its largest new stake was Beam Therapeutics: 27,550 shares worth $2.19M. The largest sale was Teladoc Health, an estimated $3.23M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Chad R. Baker's largest Q4 2021 buy was Beam Therapeutics: 27,550 shares worth $2.19M.
  • Chad R. Baker's biggest Q4 2021 reduction was Apple, cutting an estimated $1.36M.
  • Chad R. Baker fully exited Teladoc Health in Q4 2021, selling an estimated $3.23M.
  • Chad R. Baker's ten largest holdings make up 44% of its $483M portfolio in Q4 2021.
  • Chad R. Baker opened 2 new positions and closed 4 in Q4 2021.
  • Chad R. Baker's portfolio value rose 8.4% quarter-over-quarter to $483M.

Based on Chad R. Baker's 13F filing for Q4 2021, filed 8 Feb 2022.